DIVIS LABORATORIES at All Time High; BSE HEALTHCARE Index Down 0.9%
February 8, 2019 10:06 AM

DIVIS LABORATORIES share price has hit an all-time high at Rs 1,672 (up 0.3%).

Meanwhile, the BSE HEALTHCARE Index is at 14,098 (down 0.9%).

Among the top gainers in the BSE HEALTHCARE Index today are DIVIS LABORATORIES (up 0.3%) and SANOFI INDIA .

CIPLA and ALEMBIC PHARMA (down 0.1%) are among the top losers today.

Over the last one year, DIVIS LABORATORIES has moved up from Rs 1,012 to Rs 1,672, registering a gain of Rs 660 (up 65.2%).

The BSE HEALTHCARE has moved up from 13,939 to 14,098, registering a gain of 159 points during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were DIVIS LABORATORIES (up 65.2%), ABBOTT INDIA (up 52.7%) and PFIZER (up 34.7%).

What About the Benchmark Indices?

The BSE Sensex is at 36,886 (down 0.6%). The top gainers among the BSE Sensex stocks today are POWER GRID (up 1.4%), HCL TECH. (up 1.1%) and INDUSIND BANK (up 0.7%). Other gainers include NTPC (up 0.2%) and HERO MOTOCORP (up 0.1%). The most traded stocks in the BSE Sensex are COAL INDIA and POWER GRID.

In the meantime, NSE Nifty is at 11,041 (down 0.5%). The top gainers in the NSE Nifty include BHARTI INFRATEL (up 2.5%), POWER GRID (up 1.6%) and TITAN COMPANY (up 1.5%). Other gainers include BPCL (up 1.4%) and HCL TECH. (up 1.1%).

Over the last 12 months, the BSE Sensex has moved up from 34,083 to 36,886, registering a gain of 2,803 points (up 7.9%).

DIVIS LABORATORIES Financial Update...

DIVIS LABORATORIES net profit stood at Rs 4 billion for the quarter ended December 2018, compared to a profit of Rs 2 billion a year ago. Net Sales rose 29.4% to Rs 13.4 billion during the period as against Rs 10.4 billion in October-December 2017.

For the year ended March 2018, DIVIS LABORATORIES reported 17.3% decrease in net profit to Rs 8.8 billion compared to net profit of Rs 10.6 billion during FY17.

Revenue of the company grew 4.7% to Rs 39 billion during FY18.

The current Price to earnings ratio of DIVIS LABORATORIES, based on rolling 12 month earnings, stands at 34.0x.